Literature DB >> 13680408

A case of partial biotinidase deficiency associated with autism.

Marco Zaffanello1, Giorgio Zamboni, Elena Fontana, Leonardo Zoccante, Luciano Tatò.   

Abstract

We report the case of a child with partial biotinidase deficiency and autistic developmental disorder. We arrived at the diagnosis of biotinidase deficiency when the child was almost 4 years of age. Consequently, he began cofactor biotin treatment (10 mg daily) which did not resolve his autistic behavior. His younger brother was affected by partial biotinidase deficiency diagnosed at birth through our neonatal screening program. He was precociously treated with cofactor biotin therapy (10 mg daily) and did not show any behavioral abnormality or developmental delay. Since the brain is quite vulnerable to biotin deficiency, delayed biotin therapy could result in neurological damage. Our patient is the first case of partial biotinidase deficiency associated with autism. We hypothesize that the low biotinidase activity could have caused biotin deficiency in his brain and cerebrospinal fluids and consequently serious neurological problems, such as stereotyped and autistic behaviors, which were irreversible in spite of biotin supplementation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680408     DOI: 10.1076/chin.9.3.184.16457

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  8 in total

Review 1.  Neurometabolic disorders and dysfunction in autism spectrum disorders.

Authors:  Nassim Zecavati; Sarah J Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

2.  Biotin and biotinidase deficiency.

Authors:  Janos Zempleni; Yousef I Hassan; Subhashinee Sk Wijeratne
Journal:  Expert Rev Endocrinol Metab       Date:  2008-11-01

Review 3.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

4.  Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders.

Authors:  Pei-Fen Kuan; Xiaohua Yang; Roman Kotov; Sean Clouston; Evelyn Bromet; Benjamin J Luft
Journal:  Transl Psychiatry       Date:  2022-04-28       Impact factor: 7.989

Review 5.  Biomarkers in autism.

Authors:  Andre A S Goldani; Susan R Downs; Felicia Widjaja; Brittany Lawton; Robert L Hendren
Journal:  Front Psychiatry       Date:  2014-08-12       Impact factor: 4.157

Review 6.  Can psychiatric childhood disorders be due to inborn errors of metabolism?

Authors:  A Simons; F Eyskens; I Glazemakers; D van West
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-30       Impact factor: 4.785

Review 7.  Autistic feature as a presentation of Inborn Errors of Metabolism.

Authors:  Farzad Ahmadabadi; Hamid Nemati; Amirmohammad Abdolmohammadzadeh; Adel Ahadi
Journal:  Iran J Child Neurol       Date:  2020

8.  Therapeutic Effects of a Novel Form of Biotin on Propionic Acid-Induced Autistic Features in Rats.

Authors:  Kazim Sahin; Cemal Orhan; Serdar Karatoprak; Mehmet Tuzcu; Patrick Brice Defo Deeh; Ibrahim Hanifi Ozercan; Nurhan Sahin; Merve Yilmaz Bozoglan; Sarah Sylla; Sara Perez Ojalvo; James R Komorowski
Journal:  Nutrients       Date:  2022-03-17       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.